Stimulated by the double positive news, the three major U.S. stock indexes rose sharply on Friday, with the NASDAQ and the S & P 500 index reaching new highs.
The performance of vaccine stocks was also very bright, as AstraZeneca vaccine may restart the global experiment, competitors laugh, Moderna rose 16.35%, market value soared more than 40 billion.
Tesla up 20% in a week
Market value surpasses Berkshire
As of Fridays close, Teslas market value had reached $555.2 billion, surpassing Warren Buffetts Berkshire (with a market value of $543 billion) to become the sixth largest U.S. company by market value.
So far this year, Tesla has risen more than 600%.
On the news, after hours on November 16 local time, standard & Poors Dow Jones index announced that Tesla would be included in the S & P 500 index before the trading day on December 21. Teslas share price has been rising as the date of inclusion approaches.
In the inflow, Goldman said active funds would also invest about $8 billion. Analysts at Goldman Sachs said that among the 189 large cap core funds they covered, as of the end of the third quarter, 157 funds with assets of about $500 billion did not hold Tesla shares. Assuming that these funds choose to hold Tesla according to the benchmark weight, they will need to buy $8 billion of shares, about 2% of Teslas market value.
It is worth noting that while the share price soars, Tesla is also facing certain problems in terms of quality problems. According to the latest regulatory documents this week, the national highway traffic safety administration has launched a formal investigation into the front suspension safety problems of nearly 115000 Tesla vehicles. The agency said it would conduct a preliminary assessment of models 2015-2017 and modelx 2016-2017 after receiving 43 complaints about the failure of the front link of the left or right front suspension.
AstraZeneca vaccine is questioned, colleagues laugh
Moderna rose more than 16% and its market value soared by 46 billion yuan
Pascal soriot, AstraZenecas chief executive, said on Thursday that AstraZeneca might conduct a new round of global trials because of doubts about the vaccine trial.
This will have a certain negative impact on the marketing of such vaccines in the United States. Svbleerink analyst Geoffrey Porges said the AstraZeneca vaccine was unlikely to be approved in the United States as the company tried to beautify the results by emphasizing its higher effectiveness in relatively small groups of subjects in the study..
John La mattina, former president of Pfizers global R & D, said on social media that it was difficult to believe that US regulators would grant emergency use authorization for a vaccine with the best dose tested on 2300 people.
Competitors laughed, with Pfizer up 1.97%, biontech up 4.79%, Moderna up 16.35%, and its market value soared by 7.05 billion US dollars (about 46.3 billion yuan), and its closing market value exceeded 50 billion US dollars.
Trumps gone. The vaccine is coming
NASDAQ and S & P reach new heights
On the day of the holiday, there is a huge amount of information in the US market.
Trump first mentioned leaving the White House, saying, if the electoral college supports Joe Biden, he will leave the White House. He also said delivery of the new crown vaccine would start as early as next week
Last night, the three major U.S. stock indexes rose collectively, boosted by the decline in election uncertainty and the good news of vaccines.
By the end of the day, the Dow rose 0.13% to 29910.37; the NASDAQ rose 0.92% to 12205.85; and the S & P 500 index rose 0.24% to 3638.35. This week, the S & P 500 is up 2.3%, the Dow is up 2.2%, and the NASDAQ is up 3%.
Among them, the S & P 500 and the NASDAQ both reached record closing highs.
As for the future trend, Mike Wilson, chief U.S. stock strategist at Morgan Stanley, believes that due to the severe epidemic situation of the new crown in the United States and the possible economic blockade, the rise of US stocks may slow down, but the bull market will continue to be expected to continue into next year. Under the combined effect of the election results and the good news of the vaccine, investors may have to admit that the main line switch led by US stocks may not be temporary, but will last for some time. Mike Wilson advises investors not to focus too much on the performance of the index, but to look for opportunities in the bull market.
Nannette hechler fayd herbe, chief investment officer for international wealth management and head of global economics and research at Credit Suisse, said in an interview: to see if the market will continue to rise, we have to make sure that those vaccines are really promising. Therefore, now we hope to see the vaccine approved as soon as possible, and hope to see the production prospect of vaccine in a wider range of distribution.
Us blockchain concept stocks tumble
Marathon patent down 16.41%
Bitcoin has opened a deep callback mode just before the record high.
On the news, around 8:00 Beijing time on the 26th, Brian Armstrong, co-founder of coinbase, a digital currency exchange, sent more than a dozen tweets, saying that U.S. Treasury Secretary manu chin is planning to introduce new regulations on self hosting encrypted wallets before the end of his term of office.
Armstrong said the new rules, which seek to track the owners of cryptocurrency wallets and everyone involved in the transaction, will, if implemented, suppress the core principle of the cryptocurrency spirit - that private cryptocurrencies are not harassed and tracked.
Bad news, coupled with the strong willingness to take profit in the early profit, bitcoin callback more.
It rose 45% in January, and Hillhead earned 500 million yuan
Last night, station B rose 4.6% to a record high, with a market value of $22.5 billion.
Since then, the market value has risen by $4.5 billion.
The rumors of iqiyis acquisition are back to twists and turns
Opening down more than 4%
Last night, iqiyi fell more than 4% at the beginning of trading, and then rose in a straight line. The decline narrowed to 1.7% by the end of the trading.
On the news, before Fridays trading, the media reported that Alibaba and Tencent had suspended the acquisition negotiations due to differences in the value of iqiyis $20 billion valuation and anti-monopoly concerns.
In response, iqiyi said no comment and Baidu said the rumors were untrue.